I think it's important to inform patients, from the beginning, help them understand what you're going through, in terms of the regulatory end of it.
Editor's note · Context
Harkin emphasizes the need for patient advocacy in clinical trials.
Share & report
More from Tom Harkin
Mr. Presidet, this morning we convened a hearing to consider the President's nomination of Lauren McFerran to fill an impending vacancy on the National Labor Relations Board. Ms. McFerran is well known to most of us as a senior staffer on…
The Biden Administration has taken some important steps to right those wrongs, discharging student loans for borrowers who were not able to graduate.
Mr. President, I ask unanimous consent that Zachary Gross, Katy Crabtree, and Emalee Barto, interns with the Senate Health, Education, Labor, and Pensions Committee, be granted floor privileges for the remainder of today's session and that…
Mr. President, first let me thank my friend and colleague for his lifetime characteristic which is being very gracious and very generous in his remarks. Chuck Grassley and I have served together since 1974. I like to tell people that in…





